Multicenter Phase 2 Study of Oral azacitidine (CC-486) plus CHOP as initial treatment for peripheral T-cell lymphoma
Jia Ruan(Cornell University), Peter W. Martin(Cornell University), Grigorii Nos(Addgene), Vladislav Maksimov(Addgene), Ari Melnick(Cornell University), Michael Sigouros(Cornell University), Jenny Xiang(Cornell University), John P. Leonard(New York University), Koen van Besien(University Hospitals of Cleveland), Maria Sorokina(Addgene), Andrea Sboner(Cornell University), Erin Mulvey(Cornell University), Olivier Elemento(Cornell University), Alison J. Moskowitz, Neha Mehta–Shah(The University of Texas MD Anderson Cancer Center), Lubomir Sokol(Moffitt Cancer Center), Alicia Alonso(University of the Basque Country), Steven M. Horwitz(Memorial Sloan Kettering Cancer Center), María V. Revuelta(Cornell University), Sarah C. Rutherford(NewYork–Presbyterian Hospital), Nikita Kotlov(Addgene), Zhengming Chen(Cornell University), Leandro Cerchietti(Cornell University), Giorgio Inghirami(Cornell University)
Cited by 47
Related Papers
Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver
|Nature Cell Biology|2015|2.7k
Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation
|Cancer Cell|2010|2.7k
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)<sup>1</sup>
|Autophagy|2021|2.7k
Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma
|New England Journal of Medicine|2018|2.3k
Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
|New England Journal of Medicine|2012|1.9k